Can MR fluoroscopic triggering technique and slow rate injection provide appropriate arterial phase images with reducing artifacts on gadoxetic acid-DTPA (Gd-EOB-DTPA)-enhanced hepatic MR imaging?-Reference-Cited by-同舟云学术

Can MR fluoroscopic triggering technique and slow rate injection provide appropriate arterial phase images with reducing artifacts on gadoxetic acid-DTPA (Gd-EOB-DTPA)-enhanced hepatic MR imaging?

Published:2010-07-22 Issue:2 Volume:32 Page:334-340
ISSN:1053-1807
Container-title:Journal of Magnetic Resonance Imaging
language:en
Short-container-title:J. Magn. Reson. Imaging

Author:

Haradome Hiroki,Grazioli Luigi,Tsunoo Mika,Tinti Rita,Frittoli Barbara,Gambarini Sebastiana,Morone Mario,Motosugi Utaroh,Colagrande Stefano

Publisher

Wiley

Subject

Radiology, Nuclear Medicine and imaging

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jmri.22241/fullpdf

Reference17 articles.

1. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopahtologic findings and spiral CT-initial observations;Huppertz;Radiology,2004

2. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings;Huppertz;Radiology,2004

3. Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma;Kim;AJR Am J Rentogenol,2009

4. Dilution method of gadolinium ethoxybenzyl diethylenetriaminapentaacetiv acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI);Motosugi;J Magn Reson Imaging,2009

5. Fluoroscopically triggered contrast-enhanced three-dimensional MR angiography with elliptical centric view order: application to the renal arteries;Wilman;Radiology,1997

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are dilution, slow injection and care bolus technique the causal solution to mitigating arterial-phase artifacts on gadoxetic acid–enhanced MRI? A large-cohort study;European Radiology;2024-01-20

2. The timing phase affected the inconsistency of APHE subtypes of liver observations in patients at risk for HCC on the multi-hepatic arterial phase imaging;Abdominal Radiology;2024-01-10

3. Using arterial phase hyperenhancement on CT instead of gadoxetic acid arterial phase enhancement may improve the diagnostic performance for hepatocellular carcinoma;Annals of Translational Medicine;2022-11

4. Influence of dilution on arterial-phase artifacts and signal intensity on gadoxetic acid–enhanced liver MRI;European Radiology;2022-07-27

5. Fully automatic quantification of transient severe respiratory motion artifact of gadoxetate disodium–enhanced MRI during arterial phase;Medical Physics;2022-07-10